Sales 2024 * | 48.14B 44.63B | Sales 2025 * | 50.19B 46.53B | Capitalization | 211B 196B |
---|---|---|---|---|---|
Net income 2024 * | 10.05B 9.31B | Net income 2025 * | 11.03B 10.23B | EV / Sales 2024 * | 4.63 x |
Net Debt 2024 * | 11.49B 10.66B | Net Debt 2025 * | 10.14B 9.4B | EV / Sales 2025 * | 4.41 x |
P/E ratio 2024 * |
18.6
x | P/E ratio 2025 * |
16.5
x | Employees | 76,057 |
Yield 2024 * |
3.9% | Yield 2025 * |
4.03% | Free-Float | 81.95% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
1st Jan change | Capi. | |
---|---|---|
+34.63% | 701B | |
+26.24% | 571B | |
+1.20% | 381B | |
+21.05% | 334B | |
+17.17% | 319B | |
+0.74% | 210B | |
-6.05% | 201B | |
-3.35% | 157B | |
-0.96% | 153B |